359 related articles for article (PubMed ID: 28260884)
1. Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles.
Chu Y; Chen N; Yu H; Mu H; He B; Hua H; Wang A; Sun K
Int J Nanomedicine; 2017; 12():1353-1368. PubMed ID: 28260884
[TBL] [Abstract][Full Text] [Related]
2. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
[TBL] [Abstract][Full Text] [Related]
3. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization.
Alanazi JS; Alqahtani FY; Aleanizy FS; Radwan AA; Bari A; Alqahtani QH; Abdelhady HG; Alsarra I
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213977
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice.
Hu C; Chen X; Huang Y; Chen Y
Chem Biol Drug Des; 2018 Aug; 92(2):1567-1575. PubMed ID: 29722179
[TBL] [Abstract][Full Text] [Related]
6. [Research on Tat peptide-polyethylene glycol modified gelatin-siloxane nanoparticles across the blood-brain barrier].
Tian X; Wei F; Lin X; Feng W; Wang P
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Jun; 29(3):486-90, 500. PubMed ID: 22826945
[TBL] [Abstract][Full Text] [Related]
7. RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization.
Zhang J; Zhu J; Zhao L; Mao K; Gu Q; Li D; Zhao J; Wu X
J Nanobiotechnology; 2021 Jul; 19(1):196. PubMed ID: 34215269
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
Li J; Zhang X; Wang M; Li X; Mu H; Wang A; Liu W; Li Y; Wu Z; Sun K
Int J Pharm; 2016 Mar; 501(1-2):112-23. PubMed ID: 26828670
[TBL] [Abstract][Full Text] [Related]
9. Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV.
Singh SR; Grossniklaus HE; Kang SJ; Edelhauser HF; Ambati BK; Kompella UB
Gene Ther; 2009 May; 16(5):645-59. PubMed ID: 19194480
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory efficacy of intravitreal dexamethasone acetate-loaded PLGA nanoparticles on choroidal neovascularization in a laser-induced rat model.
Xu J; Wang Y; Li Y; Yang X; Zhang P; Hou H; Shi Y; Song C
J Ocul Pharmacol Ther; 2007 Dec; 23(6):527-40. PubMed ID: 18001232
[TBL] [Abstract][Full Text] [Related]
11. iRGD-mediated core-shell nanoparticles loading carmustine and O
Liu C; Yao S; Li X; Wang F; Jiang Y
J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474
[TBL] [Abstract][Full Text] [Related]
12. Targeted treatment of choroidal neovascularization using integrin-mediated sterically stabilized liposomes loaded with combretastatin A4.
Ma L; Liu YL; Ma ZZ; Dou HL; Xu JH; Wang JC; Zhang X; Zhang Q
J Ocul Pharmacol Ther; 2009 Jun; 25(3):195-200. PubMed ID: 19456253
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats.
Kim H; Csaky KG
J Control Release; 2010 Mar; 142(2):286-93. PubMed ID: 19895863
[TBL] [Abstract][Full Text] [Related]
14. Engineering PLGA nano-based systems through understanding the influence of nanoparticle properties and cell-penetrating peptides for cochlear drug delivery.
Cai H; Liang Z; Huang W; Wen L; Chen G
Int J Pharm; 2017 Oct; 532(1):55-65. PubMed ID: 28870763
[TBL] [Abstract][Full Text] [Related]
15. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.
Egusquiaguirre SP; Manguán-García C; Pintado-Berninches L; Iarriccio L; Carbajo D; Albericio F; Royo M; Pedraz JL; Hernández RM; Perona R; Igartua M
Eur J Pharm Biopharm; 2015 Apr; 91():91-102. PubMed ID: 25660910
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration.
Dai J; Han S; Ju F; Han M; Xu L; Zhang R; Sun Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):860-873. PubMed ID: 29771149
[TBL] [Abstract][Full Text] [Related]
17. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
[TBL] [Abstract][Full Text] [Related]
18. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
[TBL] [Abstract][Full Text] [Related]
19. Topical application of recombinant calreticulin peptide, vasostatin 48, alleviates laser-induced choroidal neovascularization in rats.
Bee YS; Sheu SJ; Ma YL; Lin HC; Weng WT; Kuo HM; Hsu HC; Tang CH; Liou JC; Tai MH
Mol Vis; 2010 Apr; 16():756-67. PubMed ID: 20454694
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.
Kamizuru H; Kimura H; Yasukawa T; Tabata Y; Honda Y; Ogura Y
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2664-72. PubMed ID: 11581214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
